ADH5 and CSNK2B |
alcohol dehydrogenase 5 (class III), chi polypeptide |
casein kinase 2 beta |
|
- Synthesis of PC
- WNT mediated activation of DVL
- Condensation of Prometaphase Chromosomes
- Signal transduction by L1
- Neutrophil degranulation
- Regulation of TP53 Activity through Phosphorylation
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- Receptor Mediated Mitophagy
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- Regulation of PTEN stability and activity
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
|
|
|
ADH5 and ESRRA |
alcohol dehydrogenase 5 (class III), chi polypeptide |
estrogen related receptor alpha |
|
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Transcriptional activation of mitochondrial biogenesis
- Nuclear Receptor transcription pathway
- Regulation of RUNX2 expression and activity
- Regulation of RUNX2 expression and activity
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
- Troglitazone
- Diethylstilbestrol
- Genistein
- Afimoxifene
- beta-Naphthoflavone
- 1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE
- Flavone
|
|
|
ADH5 and PRDX1 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
peroxiredoxin 1 |
|
- Detoxification of Reactive Oxygen Species
- TP53 Regulates Metabolic Genes
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
|
|
|
ADH5 and APP |
alcohol dehydrogenase 5 (class III), chi polypeptide |
amyloid beta precursor protein |
|
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Phenserine
- Tiomolibdate ion
- CAD106
- Mito-4509
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
|
|
|
ADH5 and SNTA1 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
syntrophin alpha 1 |
|
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
|
|
|
ADH5 and CHD3 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
chromodomain helicase DNA binding protein 3 |
|
- HDACs deacetylate histones
- ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
- SUMOylation of chromatin organization proteins
- Regulation of TP53 Activity through Acetylation
- RNA Polymerase I Transcription Initiation
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
|
- NADH
- Lauric Acid
- 12-Hydroxydodecanoic Acid
- S-Hydroxymethyl Glutathione
|
|
|
|
ADH6 and ARRB1 |
alcohol dehydrogenase 6 (class V) |
arrestin beta 1 |
|
- Activated NOTCH1 Transmits Signal to the Nucleus
- G alpha (s) signalling events
- Lysosome Vesicle Biogenesis
- Golgi Associated Vesicle Biogenesis
- Thrombin signalling through proteinase activated receptors (PARs)
- Activation of SMO
- Activation of SMO
- MAP2K and MAPK activation
- Ub-specific processing proteases
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Signaling downstream of RAS mutants
|
|
|
|
|
ADM and EDN1 |
adrenomedullin |
endothelin 1 |
- G alpha (s) signalling events
- Calcitonin-like ligand receptors
- ADORA2B mediated anti-inflammatory cytokines production
|
- Peptide ligand-binding receptors
- G alpha (q) signalling events
|
|
|
|
|
ADORA1 and SNF8 |
adenosine A1 receptor |
SNF8 subunit of ESCRT-II |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- Endosomal Sorting Complex Required For Transport (ESCRT)
- HCMV Late Events
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and P2RY1 |
adenosine A1 receptor |
purinergic receptor P2Y1 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- G alpha (q) signalling events
- P2Y receptors
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and ATXN1L |
adenosine A1 receptor |
ataxin 1 like |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and GNAI2 |
adenosine A1 receptor |
G protein subunit alpha i2 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- PLC beta mediated events
- PLC beta mediated events
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- G-protein activation
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and DRD1 |
adenosine A1 receptor |
dopamine receptor D1 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- Dopamine receptors
- G alpha (s) signalling events
- ADORA2B mediated anti-inflammatory cytokines production
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
- Ziprasidone
- Cabergoline
- Cabergoline
- Ropinirole
- Olanzapine
- Olanzapine
- Methylergometrine
- Clozapine
- Mirtazapine
- Thiethylperazine
- Phenylpropanolamine
- Loxapine
- Loxapine
- Pramipexole
- Promazine
- Imipramine
- Chlorpromazine
- Chlorpromazine
- Haloperidol
- Triflupromazine
- Amoxapine
- Cinnarizine
- Lisuride
- Fluphenazine
- Thioridazine
- Ergotamine
- Apomorphine
- Trimipramine
- Risperidone
- Propiomazine
- Fenoldopam
- Minaprine
- Perphenazine
- Flupentixol
- Dopamine
- Dopamine
- Carphenazine
- Ergoloid mesylate
- Acetophenazine
- Pergolide
- Bromocriptine
- Quetiapine
- Levodopa
- Aripiprazole
- Chlorprothixene
- Paliperidone
- Methotrimeprazine
- Propericiazine
- Acepromazine
- Pipotiazine
- Thioproperazine
- Thiothixene
- Zuclopenthixol
- Iloperidone
- Rotigotine
- Mianserin
- Asenapine
- Quinagolide
- Tetrahydropalmatine
- Dihydrexidine
|
|
|
ADORA1 and EPB41L2 |
adenosine A1 receptor |
erythrocyte membrane protein band 4.1 like 2 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- Neurexins and neuroligins
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and GNAO1 |
adenosine A1 receptor |
G protein subunit alpha o1 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- PLC beta mediated events
- PLC beta mediated events
- G-protein activation
- Ca2+ pathway
- Ca2+ pathway
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and GNAS |
adenosine A1 receptor |
GNAS complex locus |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
- Glucagon signaling in metabolic regulation
- PKA activation in glucagon signalling
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- G alpha (s) signalling events
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Vasopressin regulates renal water homeostasis via Aquaporins
- Hedgehog 'off' state
- ADORA2B mediated anti-inflammatory cytokines production
- ADORA2B mediated anti-inflammatory cytokines production
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
- Colforsin
- 2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE
|
|
- Fibrous dysplasia, polyostotic; Albright hereditary osteodystrophy
- Pseudohypoparathyroidism
- Progressive osseous heteroplasia (POH)
|
ADORA1 and GNAZ |
adenosine A1 receptor |
G protein subunit alpha z |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- PLC beta mediated events
- PLC beta mediated events
- G-protein activation
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- ADORA2B mediated anti-inflammatory cytokines production
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
|
|
|
ADORA1 and GRM1 |
adenosine A1 receptor |
glutamate metabotropic receptor 1 |
- Adenosine P1 receptors
- G alpha (i) signalling events
|
- G alpha (q) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- Neurexins and neuroligins
- Neurexins and neuroligins
|
- Caffeine
- Theophylline
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Gabapentin
- Aminophylline
- Oxtriphylline
- Theobromine
- Defibrotide
- Tecadenoson
- Naxifylline
- Tonapofylline
- Rolofylline
|
- Glutamic Acid
- 4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid
|
|
|
PARP1 and NRF1 |
poly(ADP-ribose) polymerase 1 |
nuclear respiratory factor 1 |
- POLB-Dependent Long Patch Base Excision Repair
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- SUMOylation of DNA damage response and repair proteins
- HDR through MMEJ (alt-NHEJ)
- DNA Damage Recognition in GG-NER
- Formation of Incision Complex in GG-NER
- Dual Incision in GG-NER
|
- PPARA activates gene expression
- Transcriptional activation of mitochondrial biogenesis
- Transcriptional activation of mitochondrial biogenesis
|
- Theophylline
- Zinc
- Carba-Nicotinamide-Adenine-Dinucleotide
- NU1025
- Nicotinamide
- 2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
- 3-Methoxybenzamide
- 2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide
- 3,4-Dihydro-5-Methyl-Isoquinolinone
- 2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide
- 6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE
- Veliparib
- trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium
- 5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE
- Olaparib
- Niraparib
- Rucaparib
|
|
|
|
ADRA2A and YWHAZ |
adrenoceptor alpha 2A |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta |
- Adrenoceptors
- Adrenaline signalling through Alpha-2 adrenergic receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (i) signalling events
- G alpha (z) signalling events
- Surfactant metabolism
|
- Activation of BAD and translocation to mitochondria
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Deactivation of the beta-catenin transactivating complex
- Rap1 signalling
- GP1b-IX-V activation signalling
- KSRP (KHSRP) binds and destabilizes mRNA
- Interleukin-3, Interleukin-5 and GM-CSF signaling
- RHO GTPases activate PKNs
- TP53 Regulates Metabolic Genes
- Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
- NOTCH4 Activation and Transmission of Signal to the Nucleus
- Negative regulation of NOTCH4 signaling
- Regulation of localization of FOXO transcription factors
|
- Amphetamine
- Bethanidine
- Ziprasidone
- Cabergoline
- Ropinirole
- Dihydroergotamine
- Amitriptyline
- Olanzapine
- Clozapine
- Norepinephrine
- Mirtazapine
- Phenylpropanolamine
- Loxapine
- Pramipexole
- Dipivefrin
- Prazosin
- Chlorpromazine
- Brimonidine
- Nortriptyline
- Amoxapine
- Amoxapine
- Clonidine
- Lisuride
- Guanabenz
- Dexmedetomidine
- Trazodone
- Epinephrine
- Phentolamine
- Ergotamine
- Tizanidine
- Apomorphine
- Trimipramine
- Risperidone
- Epinastine
- Tolazoline
- Fenoldopam
- Dobutamine
- Pseudoephedrine
- Benzphetamine
- Phenoxybenzamine
- Maprotiline
- Oxymetazoline
- Apraclonidine
- Methyldopa
- Guanfacine
- Ergoloid mesylate
- Carvedilol
- Doxepin
- Nefazodone
- Desipramine
- Pergolide
- Bromocriptine
- Quetiapine
- Aripiprazole
- Paliperidone
- Ephedra
- Mephentermine
- Yohimbine
- Methotrimeprazine
- 4-Methoxyamphetamine
- Methamphetamine
- Propericiazine
- Zuclopenthixol
- Dronedarone
- Lofexidine
- Epicept NP-1
- Mianserin
- Asenapine
- Droxidopa
- Flupirtine
- Esmirtazapine
- Xylometazoline
- Levonordefrin
- Naphazoline
- Lurasidone
- Dosulepin
- Etoperidone
- Cirazoline
- Moxonidine
- Setiptiline
- Rilmenidine
- Tiapride
|
|
|
|